Cargando…

A Guide for Pain Management in Low and Middle Income Communities. Managing the Risk of Opioid Abuse in Patients with Cancer Pain

Most patients who present with cancer have advanced disease and often suffer moderate to severe pain. Opioid therapy can be safe and effective for use in cancer patients with pain, but there are rightful concerns about inappropriate opioid use even in the cancer population. Since cancer patients liv...

Descripción completa

Detalles Bibliográficos
Autores principales: Pergolizzi, Joseph V., Zampogna, Gianpietro, Taylor, Robert, Gonima, Edmundo, Posada, Jose, Raffa, Robert B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771925/
https://www.ncbi.nlm.nih.gov/pubmed/26973529
http://dx.doi.org/10.3389/fphar.2016.00042
_version_ 1782418471434321920
author Pergolizzi, Joseph V.
Zampogna, Gianpietro
Taylor, Robert
Gonima, Edmundo
Posada, Jose
Raffa, Robert B.
author_facet Pergolizzi, Joseph V.
Zampogna, Gianpietro
Taylor, Robert
Gonima, Edmundo
Posada, Jose
Raffa, Robert B.
author_sort Pergolizzi, Joseph V.
collection PubMed
description Most patients who present with cancer have advanced disease and often suffer moderate to severe pain. Opioid therapy can be safe and effective for use in cancer patients with pain, but there are rightful concerns about inappropriate opioid use even in the cancer population. Since cancer patients live longer than ever before in history (and survivors may have long exposure times to opioid therapy), opioid misuse among cancer patients is an important topic worthy of deeper investigation. Cancer patients with pain must be evaluated for risk factors for potential opioid misuse and aberrant drug-taking behaviors assessed. A variety of validated screening tools should be used. Of particular importance is the fact that pain in cancer patients changes frequently, whether it is related to their underlying disease (progression or remission), pain related to treatment (such as painful chemotherapy-induced peripheral neuropathy), and concomitant pain unrelated to cancer (such as osteoarthritis, headache, or back pain). Fortunately, clinicians can use universal precautions to help reduce the risk of opioid misuse while still assuring that cancer patients get the pain therapy they need. Another important new “tool” in this regard is the emergence of abuse-deterrent opioid formulations.
format Online
Article
Text
id pubmed-4771925
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-47719252016-03-11 A Guide for Pain Management in Low and Middle Income Communities. Managing the Risk of Opioid Abuse in Patients with Cancer Pain Pergolizzi, Joseph V. Zampogna, Gianpietro Taylor, Robert Gonima, Edmundo Posada, Jose Raffa, Robert B. Front Pharmacol Pharmacology Most patients who present with cancer have advanced disease and often suffer moderate to severe pain. Opioid therapy can be safe and effective for use in cancer patients with pain, but there are rightful concerns about inappropriate opioid use even in the cancer population. Since cancer patients live longer than ever before in history (and survivors may have long exposure times to opioid therapy), opioid misuse among cancer patients is an important topic worthy of deeper investigation. Cancer patients with pain must be evaluated for risk factors for potential opioid misuse and aberrant drug-taking behaviors assessed. A variety of validated screening tools should be used. Of particular importance is the fact that pain in cancer patients changes frequently, whether it is related to their underlying disease (progression or remission), pain related to treatment (such as painful chemotherapy-induced peripheral neuropathy), and concomitant pain unrelated to cancer (such as osteoarthritis, headache, or back pain). Fortunately, clinicians can use universal precautions to help reduce the risk of opioid misuse while still assuring that cancer patients get the pain therapy they need. Another important new “tool” in this regard is the emergence of abuse-deterrent opioid formulations. Frontiers Media S.A. 2016-03-01 /pmc/articles/PMC4771925/ /pubmed/26973529 http://dx.doi.org/10.3389/fphar.2016.00042 Text en Copyright © 2016 Pergolizzi, Zampogna, Taylor, Gonima, Posada and Raffa. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Pergolizzi, Joseph V.
Zampogna, Gianpietro
Taylor, Robert
Gonima, Edmundo
Posada, Jose
Raffa, Robert B.
A Guide for Pain Management in Low and Middle Income Communities. Managing the Risk of Opioid Abuse in Patients with Cancer Pain
title A Guide for Pain Management in Low and Middle Income Communities. Managing the Risk of Opioid Abuse in Patients with Cancer Pain
title_full A Guide for Pain Management in Low and Middle Income Communities. Managing the Risk of Opioid Abuse in Patients with Cancer Pain
title_fullStr A Guide for Pain Management in Low and Middle Income Communities. Managing the Risk of Opioid Abuse in Patients with Cancer Pain
title_full_unstemmed A Guide for Pain Management in Low and Middle Income Communities. Managing the Risk of Opioid Abuse in Patients with Cancer Pain
title_short A Guide for Pain Management in Low and Middle Income Communities. Managing the Risk of Opioid Abuse in Patients with Cancer Pain
title_sort guide for pain management in low and middle income communities. managing the risk of opioid abuse in patients with cancer pain
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771925/
https://www.ncbi.nlm.nih.gov/pubmed/26973529
http://dx.doi.org/10.3389/fphar.2016.00042
work_keys_str_mv AT pergolizzijosephv aguideforpainmanagementinlowandmiddleincomecommunitiesmanagingtheriskofopioidabuseinpatientswithcancerpain
AT zampognagianpietro aguideforpainmanagementinlowandmiddleincomecommunitiesmanagingtheriskofopioidabuseinpatientswithcancerpain
AT taylorrobert aguideforpainmanagementinlowandmiddleincomecommunitiesmanagingtheriskofopioidabuseinpatientswithcancerpain
AT gonimaedmundo aguideforpainmanagementinlowandmiddleincomecommunitiesmanagingtheriskofopioidabuseinpatientswithcancerpain
AT posadajose aguideforpainmanagementinlowandmiddleincomecommunitiesmanagingtheriskofopioidabuseinpatientswithcancerpain
AT raffarobertb aguideforpainmanagementinlowandmiddleincomecommunitiesmanagingtheriskofopioidabuseinpatientswithcancerpain
AT pergolizzijosephv guideforpainmanagementinlowandmiddleincomecommunitiesmanagingtheriskofopioidabuseinpatientswithcancerpain
AT zampognagianpietro guideforpainmanagementinlowandmiddleincomecommunitiesmanagingtheriskofopioidabuseinpatientswithcancerpain
AT taylorrobert guideforpainmanagementinlowandmiddleincomecommunitiesmanagingtheriskofopioidabuseinpatientswithcancerpain
AT gonimaedmundo guideforpainmanagementinlowandmiddleincomecommunitiesmanagingtheriskofopioidabuseinpatientswithcancerpain
AT posadajose guideforpainmanagementinlowandmiddleincomecommunitiesmanagingtheriskofopioidabuseinpatientswithcancerpain
AT raffarobertb guideforpainmanagementinlowandmiddleincomecommunitiesmanagingtheriskofopioidabuseinpatientswithcancerpain